Formulary Search Results for: DARBEPOETIN ALFA
6.5.1 Hypothalamic and anterior pituitary hormones and anti-oestrogens - View Category
2.8.4 Reversal of anticoagulation - View Category
Restrictions:
Restricted to use only on the advice of a Consultant Haematologist for the reversal of anticoagulation in adults treated with a direct factor Xa inhibitor where there is life-threatening or uncontrolled bleeding. In addition, use should be in accordance with the local protocol (in development).
9.8.1 Drugs used in metabolic disorders - View Category
Restrictions:
Use for the long-term enzyme replacement therapy in patients with type 1 Gaucher disease is restricted to specialist use under the supervision of a physician experienced in the management of patients with Gaucher disease.
9.8.1 Drugs used in metabolic disorders - View Category
Restrictions:
Restricted to specialist use as an enzyme-replacing therapy for the treatment of non-neurological manifestations in patients with mild to moderate alpha-mannosidosis via the Ultra Orphan Pathway.
9.8.1 Drugs used in metabolic disorders - View Category
Restrictions:
Restricted to specialist use for long-term enzyme replacement therapy in adult patients with a confirmed diagnosis of Fabry disease (deficiency of alpha-galactosidase). Further restricted to those who are symptomatic and would usually be offered an enzyme replacement therapy.
5.3.3 Viral hepatitis - View Category
Restrictions:
Restricted to specialist use only. Restricted to use in adults for the treatment of hepatitis C in combination with ribavirin in accordance with Hepatitis MCN protocol.